Alexandrou, S., Lee, C. S., Fernandez, K. J., Wiharja, C. E., Eshraghi, L., Reeves, J., . . . Caldon, C. E. (2025). JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer. Journal of experimental & clinical cancer research, 44(1), 244-24. https://doi.org/10.1186/s13046-025-03466-9
Citace podle Chicago (17th ed.)Alexandrou, Sarah, et al. "JNK Pathway Suppression Mediates Insensitivity to Combination Endocrine Therapy and CDK4/6 Inhibition in ER+ Breast Cancer." Journal of Experimental & Clinical Cancer Research 44, no. 1 (2025): 244-24. https://doi.org/10.1186/s13046-025-03466-9.
Citace podle MLA (9th ed.)Alexandrou, Sarah, et al. "JNK Pathway Suppression Mediates Insensitivity to Combination Endocrine Therapy and CDK4/6 Inhibition in ER+ Breast Cancer." Journal of Experimental & Clinical Cancer Research, vol. 44, no. 1, 2025, pp. 244-24, https://doi.org/10.1186/s13046-025-03466-9.